When the team feels it’s “still working,” it’s important to identify new technology solutions with founders and developers who have experience with the legacy system. Often, their modern solution offers better efficiency and other benefits driven by their experience. Understand the potential efficiencies, work together to develop metrics from those claims and put milestones in place to prove them.

To build a successful alliance, healthtech innovators should be steeped in pharmaceutical knowledge, experience, and expertise and implement a pharma-first/tech-second approach. Pharma should reciprocate with a willingness to adopt the change management needed to modernize outdated legacy processes.

The mission of clinical development is to shorten the window between an investigational new drug application and regulatory approval, so why is it the technological black hole of pharma?

Donna Conory, MS, founder and CEO of SciMar ONE, has been accepted into Forbes Technology Council, an invitation-only community for world-class CIOs, CTOs, and technology executives.

Clinical data analytics technology innovator becomes newest member of Microsoft’s global program designed to help startups quickly build and scale.   ALLENTOWN, N.J., March 30, 2021 /PRNewswire/ — SciMar ONE™, a clinical data analytics technology company, announced today it has been selected as the newest member of Microsoft for Startups to help scale its proprietary […]

Senior financial executive and early-stage investment expert Elliot Reiff to advise on SciMar ONE’s financial strategy and operations.

Ganesh Mani, Ph.D., MBA Joins SciMar ONE’s Board of Advisors

Kathleen Hurtado, RPh, Joins SciMar ONE’s Board of Advisors

SciMar ONE (SciMar) is excited to welcome Daniel (Dan) Langille to its Board of Advisors as Microsoft partnership and alliance advisor.

Donna Conroy named 2021 Top 10 Most Successful Women in Cloud Entrepreneurs